StockStory, an investment research platform, has identified Monster Beverage as an S&P 500 constituent positioned to outperform the market, while flagging Twilio and Baxter International as stocks that may face headwinds. The analysis contrasts the strong operational metrics of the energy drink maker with the slower growth and profitability concerns affecting the communications and healthcare firms.
Monster Beverage, which was founded in 2002 as a natural soda and juice company before becoming a pioneer in the energy drink category, currently has a market capitalization of $92.66 billion. StockStory cites the company's excellent operating margin of 28.6% as evidence of an efficient business model that has leveraged fixed costs to increase profits. The firm describes Monster as a "free cash flow machine" with the flexibility to fund growth initiatives or return capital to shareholders. Additionally, StockStory points to an industry-leading return on capital of 35.4%, attributing this to management's ability to identify high-return investments. At a share price of $47.46, Monster trades at a forward price-to-earnings ratio of 37.9x.
In contrast, Twilio, a communications platform provider with a market cap of $38.95 billion, is viewed less favorably. The company, known for its "Twilio Magic" demo that allows developers to create communications apps quickly, reported annual revenue growth of 14.7% over the last two years, a pace StockStory notes was slower than its software peers. Twilio's gross margin stands at 48.6%, reflecting high servicing costs, although operating profits have increased over the past year due to improved efficiency and leverage on fixed costs. With the stock priced at $254.75, Twilio carries a forward price-to-sales valuation of 6.7x.
Baxter International, a healthcare products manufacturer with a market cap of $13.26 billion, is also subject to bearish commentary from StockStory. The company, which dates back to 1931 and sells products in over 100 countries, includes dialysis therapies and IV solutions in its portfolio. StockStory states that Baxter's constant currency growth has fallen below its standards over the past two years, suggesting a need for product improvements. Over the last five years, Baxter's earnings per share declined by 8.5% annually, outpacing its revenue drop and indicating that each sale became less profitable. The firm also notes negative returns on capital, implying that some growth strategies have not yielded expected results. Baxter shares trade at $25.45, representing a forward price-to-earnings multiple of 11.9x.
StockStory promotes its AI-driven platform for identifying momentum stocks, citing past picks such as Nvidia and Exlservice as examples of companies that delivered significant gains between June 2020 and June 2025.